{"title":"Current trends in household food insecurity, dietary diversity, and stunting among children under five in Asia: a systematic review.","authors":"Binish Islam, Tasiu Ibrahim Ibrahim, Tingting Wang, Mingyang Wu, Jiabi Qin","doi":"10.7189/jogh.15.04049","DOIUrl":"10.7189/jogh.15.04049","url":null,"abstract":"<p><strong>Background: </strong>Household food insecurity (HFI) and poor dietary diversity (DD) are major public health challenges in Asia, greatly contributing to stunting among children under five. While previous research has focussed primarily on African regions, this systematic review provides novel insights into the association between HFI, DD, and stunting within the Asian context.</p><p><strong>Methods: </strong>We searched across six major databases for studies published between 2019 and 2023 exploring the association between HFI, DD, and stunting in children under five across Asia. We then extracted their characteristics, evaluation methods, and outcomes related to stunting for analysis.</p><p><strong>Results: </strong>From 3215 records, 37 met the inclusion criteria. Most studies were from South Asia (n = 22), followed by Southeast Asia (n = 8), with fewer from West (n = 4), East (n = 2), and Central Asia (n = 1), highlighting geographical research gaps. We found high stunting rates among children under five, especially in South and Southeast Asia. Stunting was strongly linked to HFI and poor DD, suggesting that these factors are critical in addressing malnutrition. Socioeconomic factors, maternal education, and access to clean water also influence stunting outcomes.</p><p><strong>Conclusions: </strong>Current research on HFI, DD, and stunting in Asia shows substantial variation, with the highest stunting rates in South and Southeast Asia. Limited data from Central and East Asia highlights the need for more comprehensive research in these regions. Addressing HFI and improving DD is critical for reducing stunting and achieving global nutrition targets by 2030.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04049"},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association of steatotic liver disease with all-cause and cardiovascular mortality among prehypertensive or hypertensive patients.","authors":"Shiwei Yan, Qian Li, Wenzhe Cao, Haolong Pei, Shihan Zhen, Qingyao Wu, Xueli Yang, Fengchao Liang","doi":"10.7189/jogh.15.04003","DOIUrl":"https://doi.org/10.7189/jogh.15.04003","url":null,"abstract":"<p><strong>Background: </strong>Prehypertension and hypertension often coexist with non-alcoholic fatty liver disease (NAFLD) during the progression of cardiovascular disease (CVD). International academic liver societies have recently reached a consensus to replace NAFLD with the new term 'steatotic liver disease' (SLD). In this study, we aimed to evaluate the impact of different SLD subtypes on all-cause and CVD mortality in individuals with prehypertension or hypertension.</p><p><strong>Methods: </strong>We included 6074 adults from the National Health and Nutrition Examination Survey (2003-18). The US fatty liver index was used as the diagnostic criterion for SLD, and participants were classified into no SLD, metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated and alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD). For cases of MASLD, MetALD, and ALD, we further assessed advanced fibrosis using the fibrosis-4 (FIB-4) index. Additionally, we calculated hazard ratios (HRs) and 95% confidence intervals (CIs) using Cox proportional hazards regression models to assess the associations of SLD subtypes and advanced fibrosis with all-cause and CVD mortality.</p><p><strong>Results: </strong>There were 3505 (57.7%) participants with no SLD, 1284 (21.1%) with MASLD, 777 (12.8%) with MetALD, and 508 (8.4%) with ALD. During a median follow-up period of 8.2 years, the risk of all-cause and CVD mortality progressively increased in participants with MASLD (HR = 1.28; 95% CI = 1.01-1.63 and HR = 1.55; 95% CI = 1.04-2.33, respectively), MetALD (HR = 1.41; 95% CI = 1.05-1.88 and HR = 1.78; 95% CI = 1.10-2.87, respectively), and ALD (HR = 1.83; 95% CI = 1.32-2.53 and HR = 1.80; 95% CI = 1.01-3.19, respectively). Among the individuals with MASLD, MetALD, and ALD, advanced fibrosis was also associated with an increased risk of all-cause and CVD mortality.</p><p><strong>Conclusions: </strong>Individuals with MASLD, MetALD, and ALD had a higher risk of all-cause and CVD mortality than those without SLD. Therefore, early intervention strategies targeting SLD prevention and management may help individuals with prehypertension and hypertension to improve their long-term health.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04003"},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The impact of long-term prescription policy on primary care utilisation and costs among hypertensive patients in China: a six-year longitudinal study.","authors":"Chunlu Yu, Lei Zhang, Luying Zhang, Wen Chen","doi":"10.7189/jogh.15.04021","DOIUrl":"https://doi.org/10.7189/jogh.15.04021","url":null,"abstract":"<p><strong>Background: </strong>China has recently implemented a long-term prescription policy as a component of the family doctor system in order to strengthen chronic disease management. In this study, we evaluated the net policy impact on health care utilisation and costs at community health centres (CHCs) among hypertensive patients.</p><p><strong>Methods: </strong>The study population included 164 857 hypertensive patients from a provincial capital city in Eastern China, with an average age of 69.93 years in 2014. We collected their health care utilisation and costs from 1 January 2014 to 31 December 2019 from the medical insurance claims database. The long-term prescription policy, implemented in 2018, allows patients registered with family doctors to obtain up to three-month prescriptions. We applied the multi-stage difference-in-differences model to examine the policy's impact, comparing health care utilisation and costs between those eligible and for the long-term prescription policy and those who are not.</p><p><strong>Results: </strong>The long-term prescription policy significantly reduced hypertensive patients' annual outpatient visits by 2.47 at CHCs and 0.18 at pharmacies, as well as prolonged the interval of prescriptions by 3.10 days at CHCs. It decreased the annual drug costs at pharmacies by 47%, but there was no significant effect on the annual outpatient costs at CHCs. Meanwhile, we did not observe the impact of the long-term prescription policy on patients' annual number of hospitalisations.</p><p><strong>Conclusions: </strong>The long-term prescription policy mainly affected patients' health care utilisation at CHCs and did facilitate patients with chronic diseases to refill drugs conveniently. The policy impact on patient health outcomes needs to be further observed and more attention should be given to the factors that may influence family doctors' behaviour in delivering the long-term prescription service.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04021"},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kedir Y Ahmed, Subash Thapa, Getiye D Kibret, Habtamu M Bizuayehu, Jing Sun, M Mamun Huda, Abel F Dadi, Felix A Ogbo, Shakeel Mahmood, Muhammad J A Shiddiky, Fentaw T Berhe, Setognal B Aychiluhm, Anayochukwu E Anyasodor, Allen G Ross
{"title":"Population attributable fractions for modifiable risk factors of neonatal, infant, and under-five mortality in 48 low- and middle-income countries.","authors":"Kedir Y Ahmed, Subash Thapa, Getiye D Kibret, Habtamu M Bizuayehu, Jing Sun, M Mamun Huda, Abel F Dadi, Felix A Ogbo, Shakeel Mahmood, Muhammad J A Shiddiky, Fentaw T Berhe, Setognal B Aychiluhm, Anayochukwu E Anyasodor, Allen G Ross","doi":"10.7189/jogh.15.04015","DOIUrl":"https://doi.org/10.7189/jogh.15.04015","url":null,"abstract":"<p><strong>Background: </strong>Identifying the modifiable risk factors for childhood mortality using population-attributable fractions (PAFs) estimates can inform public health planning and resource allocation in low- and middle-income countries (LMICs). We estimated PAFs for key population-level modifiable risk factors of neonatal, infant, and under-five mortality in LMICs.</p><p><strong>Methods: </strong>We used the most recent Demographic and Health Survey data sets (2010-22) from 48 LMICs, encompassing 35 sub-Saharan African countries and 13 countries from South and Southeast Asia (n = 506 989). We used generalised linear latent mixed models to compute odds ratios (ORs), and we calculated the PAFs adjusted for commonality using ORs and prevalence estimates for key modifiable risk factors.</p><p><strong>Results: </strong>The highest PAFs of neonatal mortality were attributed to delayed initiation of breastfeeding (>1 hour of birth) (PAF = 23.9; 95% confidence interval (CI) = 23.1, 24.8), uncleaned cooking fuel (PAF = 6.2; 95% CI = 6.4, 7.8), infrequent antenatal care (ANC) visits (PAF = 4.3; 95% CI = 3.3, 5.9), maternal lack of formal education (PAF = 3.9; 95% CI = 2.7, 5.3), and mother's lacking two doses of tetanus injections (PAF = 3.0; 95% CI = 1.9, 3.9). These five modifiable risk factors contributed to 41.4% (95% CI = 35.6, 47.0) of neonatal deaths in the 48 LMICs. Similarly, a combination of these five risk factors contributed to 40.5% of infant deaths. Further, delayed initiation of breastfeeding (PAF = 15.8; 95% CI = 15.2, 16.2), unclean cooking fuel (PAF = 9.6; 95% CI = 8.4, 10.7), mothers lacking formal education (PAF = 7.9; 95% CI = 7.0, 8.9), infrequent ANC visits (PAF = 4.0; 95% CI = 3.3, 4.7), and poor toilet facilities (PAF = 3.4; 95% CI = 2.6, 4.3) were attributed to 40.8% (95% CI = 36.4, 45.2) of under-five deaths.</p><p><strong>Conclusions: </strong>Given the current global economic climate, policymakers should prioritise these modifiable risk factors. Key recommendations include ensuring that women enter pregnancy in optimal health, prioritising the presence of skilled newborn attendants for timely and proper breastfeeding initiation, and enhancing home-based care during the postnatal period and beyond.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04015"},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yi Liu, Xuanyin Huang, Ke Tang, Jing Wu, Jiali Zhou, He Bai, Liying Zhou, Shiyi Shan, Zeyu Luo, Jin Cao, Peige Song, Igor Rudan
{"title":"Prevalence of osteoporosis and associated factors among Chinese adults: a systematic review and modelling study.","authors":"Yi Liu, Xuanyin Huang, Ke Tang, Jing Wu, Jiali Zhou, He Bai, Liying Zhou, Shiyi Shan, Zeyu Luo, Jin Cao, Peige Song, Igor Rudan","doi":"10.7189/jogh.15.04009","DOIUrl":"https://doi.org/10.7189/jogh.15.04009","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a degenerative disease of bone metabolism. The epidemiology of osteoporosis varies by age, sex, and geography. There is a lack of information on the prevalence of osteoporosis among Chinese adults. In this study, we aimed to estimate the prevalence of osteoporosis among Chinese adults by age, sex, and skeletal sites and explore the main associated factors.</p><p><strong>Methods: </strong>We searched six bibliographic databases to identify epidemiological studies that reported the prevalence of osteoporosis among Chinese adults published between January 1990 and February 2022. We applied a multilevel mixed-effects meta-regression to estimate the age-specific prevalence of osteoporosis. We presented the age-specific prevalence of osteoporosis by sex, diagnostic criteria (World Health Organization (WHO) and Chinese (CHN) diagnostic criteria), and specific skeletal site (the lumbar spine, femoral neck, and ward's triangle). We used the population data from the seventh National Census of Mainland China to estimate the number of Chinese adults with osteoporosis in 2020. Major associated factors for osteoporosis were pooled by a random-effects meta-analysis. We also estimated the regional prevalence and cases of osteoporosis among 31 provinces in mainland China in 2020 using an 'associated factor-based model.'</p><p><strong>Results: </strong>We included 129 articles in this systematic review and modelling study. 32 were based on the WHO diagnostic criteria and 17 on the CHN diagnostic criteria. Additionally, we included 83 articles in the associated factor analysis. The prevalence of osteoporosis increased with age and was consistently higher in females than males, regardless of diagnostic criteria and skeletal sites. Whether based on the WHO criteria (13.54%, 95% confidence interval (CI) = 10.25, 18.11) or the CHN criteria (29.49%, 95% CI = 18.29, 43.5), the prevalence of osteoporosis among Chinese adults aged 20-89 years in 2020 was highest when measuring the ward's triangle, which translated to 145.86 million (95% CI = 110.41, 195.03) and 317.54 million (95% CI = 196.95, 468.47) affected adults, respectively. The prevalence of osteoporosis was the highest in Northeast China under both the WHO criteria (15.50%, 95% CI = 11.78, 20.59) and the CHN criteria (32.36%, 95% CI = 20.33, 46.8), with the ward being the measured skeletal site. Marital status, current smoking, underweight, hypertension, fracture history, longer menopause years and menopause were positively associated with osteoporosis.</p><p><strong>Conclusions: </strong>Osteoporosis remains a significant public health concern in China, particularly among females and the elderly. Meanwhile, the prevalence of osteoporosis varies considerably by region, skeletal site and diagnostic criteria. It is essential to establish clear and unified diagnostic criteria and implement high-quality epidemiological studies for osteoporosis in China. Additionally, tar","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04009"},"PeriodicalIF":4.5,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yang Wang, Hua Jin, Hui Yang, Yang Zhao, Yi Qian, Dehua Yu, Hai Fang
{"title":"Primary care functional features and their health impact on patients enrolled in the Shanghai family doctor service: a mixed-methods study.","authors":"Yang Wang, Hua Jin, Hui Yang, Yang Zhao, Yi Qian, Dehua Yu, Hai Fang","doi":"10.7189/jogh.15.04007","DOIUrl":"10.7189/jogh.15.04007","url":null,"abstract":"<p><strong>Background: </strong>While research in multiple countries confirms that primary care functional features significantly improve patient health, China's primary care system differs markedly due to unique structural and contextual factors. This study aims to measure and explore the functional features experienced by patients received family doctor contract service in the past year, evaluating the impacts and pathways of these primary care features on health outcomes.</p><p><strong>Methods: </strong>We employed a mixed-methods explanatory sequential design. In the quantitative phase, we randomly selected 2118 residents from 12 primary care institutions. The intensity of functional features was assessed using the Person-Centered Primary Care Measure (PCPCM), and their association with levels of EuroQol Visual Analogue Scale (EQ VAS) was evaluated through multilevel modelling. In the qualitative phase, a qualitative description approach was used, conducting 24 focus groups with a total of 85 patients to gather in-depth information about their experiences with functional features and perceived health impacts. Finally, the quantitative and qualitative data were integrated using meta-synthesis and joint display methods to validate, interpret, and expand the results.</p><p><strong>Results: </strong>The average PCPCM score was 3.65, with subdomain scores ranging from 3.39 to 3.83. Qualitative findings confirmed the quantitative results regarding the intensity and manifestation of features like accessibility, coordination, and relationship-building. However, discrepancies were noted in features such as comprehensiveness, integration, and family and community context. Additionally, two new functional features, 'being appreciated' and 'being cared for,' were identified. The quantitative results also showed that higher PCPCM scores were positively associated with EQ VAS levels (odds ratio (OR) = 1.18; 95% confidence interval (CI) = 1.03-1.35, P < 0.001). Furthermore, qualitative results revealed six key pathways supporting the beneficial effects of local primary care functional features on health maintenance and improvement.</p><p><strong>Conclusions: </strong>This study demonstrates high functional scores for Shanghai's family doctor services and highlights a positive association between primary care functionality and population health. These features and their health benefits are deeply shaped by the local social and health care context. This confirms the progress of Shanghai's primary care development and underscores the need for further exploration of primary care functional features across China, along with the development of tools tailored to local conditions to better measure and improve primary care quality and health outcomes.</p><p><strong>Keywords: </strong>primary healthcare; primary care; quality measurement; population health; mixed method research; China.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04007"},"PeriodicalIF":4.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142957305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mogahid Gadallh A Abdallh, Sahar Hemeda, Mohammed Elmadani, Bashir Ibrahim, Abd Elbasit Elawad Ahmed
{"title":"Epidemiology, risk factors, and awareness of mycetoma among residents in Eastern Sinnar locality, Sudan, 2021.","authors":"Mogahid Gadallh A Abdallh, Sahar Hemeda, Mohammed Elmadani, Bashir Ibrahim, Abd Elbasit Elawad Ahmed","doi":"10.7189/jogh.15.04005","DOIUrl":"10.7189/jogh.15.04005","url":null,"abstract":"<p><strong>Background: </strong>Mycetoma is a chronic granulomatous disease affecting the skin, subcutaneous tissues, and bones, particularly in tropical and subtropical regions. Sudan, especially its Eastern Sinnar locality, experiences a significant burden due to environmental conditions and limited access to healthcare, while the population's lack of awareness and understanding often leads to delays in diagnosis and treatment.</p><p><strong>Methods: </strong>We conducted a descriptive cross-sectional, community-based study in Eastern Sinnar, Sudan, to investigate the prevalence, risk factors, and awareness of mycetoma among local residents. Using Cochran's formula, we calculated a required sample size of 400 participants from a total population of 245 201. Then, we randomly selected these participants from five villages chosen through stratified sampling. Data were collected via a validated questionnaire assessing sociodemographic characteristics and mycetoma-related information, a review of medical records to confirm infection types and prevalence, and interviews with the Directorate of the Mycetoma Centre in Sinnar. We used χ<sup>2</sup> tests for associations in our analysis, with P-values ≤0.05 indicating statistical significance.</p><p><strong>Results: </strong>The mycetoma prevalence was 5.4%, with males comprising 76.4% of infected cases. However, the difference in infection rates between genders was not statistically significant (P = 0.248). While infection rates were higher among certain occupational groups, such as farmers and shepherds, the association between occupation and mycetoma infection was non-significant (P = 0.107). We also found no significant associations with educational level (P = 0.104) or age (P = 0.514), but did detect significant associations for family history of infection (P < 0.001), animal ownership (P = 0.004), and not wearing shoes during work (P = 0.05). Awareness of mycetoma was relatively high, with 78.3% of respondents acknowledging the disease, though knowledge gaps remained, especially regarding its transmission, with only 36.1% believing it to be transmissible.</p><p><strong>Conclusions: </strong>The study highlights the need for targeted health education programmes, particularly emphasising protective footwear and safe animal-handling practices. These findings are crucial for informing public health strategies aimed at reducing the burden of mycetoma in endemic regions such as Eastern Sinnar.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04005"},"PeriodicalIF":4.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142957303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haileab Fekadu Wolde, Archie Ca Clements, Kefyalew Addis Alene
{"title":"Health system and environmental factors affecting global progress towards achieving End TB targets between 2015 and 2020.","authors":"Haileab Fekadu Wolde, Archie Ca Clements, Kefyalew Addis Alene","doi":"10.7189/jogh.15.04004","DOIUrl":"10.7189/jogh.15.04004","url":null,"abstract":"<p><strong>Background: </strong>Health system and environmental factors play a significant role in achieving the World Health Organization (WHO) End Tuberculosis (TB) targets. However, quantitative measures are scarce or non-existent at a global level. We aimed to measure the progress made towards meeting the global End TB milestones from 2015 to 2020 and identify health system and environmental factors contributing to the success.</p><p><strong>Methods: </strong>We obtained data from ten different online data repositories and used principal component analysis to create domain-specific health system performance measures. We used radar charts and dumbbell plots to show the country's progress in ending TB with their health systems. Lastly, we used a linear regression model to identify key health systems and environmental predictors of the percent reduction in TB incidence and mortality.</p><p><strong>Results: </strong>There was a high variation in TB incidence and mortality reduction between countries and WHO regions. Of all countries included, 75 (39.3%) achieved more than a 20% reduction in TB incidence between 2015 and 2020. However, only 31 (16.2%) reached a 35% reduction in TB mortality. The European Region achieved the highest incidence reduction, exceeding the 2020 milestone with a 25% reduction. The African Region also made notable progress, achieving an 18% mortality reduction despite its relatively poor health systems. Health system factors, such as TB financing, TB-specific health service delivery, access to medicine, and governance, were significantly associated with TB mortality reduction between 2015 and 2020. Environmental factors, such as average annual temperature and air particulate matter concentration, were found to have a significant negative effect on TB incidence and mortality reduction.</p><p><strong>Conclusions: </strong>Weak health systems were identified as major barriers to achieving the End TB milestones in most high-burden countries. Hence, strengthening health systems with a special focus on TB financing, service delivery, and access to medicine in these countries should be prioritised to achieve global TB mortality reduction targets. Countries should follow WHO's air quality guidelines and rapidly reduce carbon dioxide and other greenhouse gas emissions to mitigate the impact of environmental factors.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04004"},"PeriodicalIF":4.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142957304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sahar Raza, Rajon Banik, Syed Toukir Ahmed Noor, Esrat Jahan, Abu Sayeed, Nafisa Huq, Shams El Arifeen, Anisuddin Ahmed, Ahmed Ehsanur Rahman
{"title":"Assessing health systems' capacities to provide post-abortion care: insights from seven low- and middle-income countries.","authors":"Sahar Raza, Rajon Banik, Syed Toukir Ahmed Noor, Esrat Jahan, Abu Sayeed, Nafisa Huq, Shams El Arifeen, Anisuddin Ahmed, Ahmed Ehsanur Rahman","doi":"10.7189/jogh.15.04020","DOIUrl":"10.7189/jogh.15.04020","url":null,"abstract":"<p><strong>Background: </strong>Abortion-related complications significantly contribute to maternal morbidity and mortality globally. Post-abortion care (PAC) services are essential to safeguarding women's rights by substantially mitigating the health risks associated with abortions - a step which is fundamental to achieving reproductive and maternal health-related Sustainable Development Goals.</p><p><strong>Methods: </strong>We conducted a secondary analysis of data from the nationally representative Service Provision Assessment (SPA) surveys conducted between 2015 and 2024 across three regions in seven low- and middle-income countries: Afghanistan, Bangladesh, Nepal, the Democratic Republic of Congo (DRC), Ethiopia, Senegal, and Haiti. We included 2951 primary facilities and 473 referral facilities offering normal delivery services. We used PAC signal functions to report capacity to provide basic and comprehensive PAC services in primary and referral facilities, respectively.</p><p><strong>Results: </strong>Of all primary facilities offering normal delivery services, 50% in Afghanistan, 1% in Bangladesh, 8% in Nepal, 5% in DRC, 34% in Ethiopia, 38% in Senegal, and 19% in Haiti had the capacity to provide basic PAC services. Of the referral facilities, 47% in Afghanistan, 16% in Bangladesh, 50% in Nepal, 52% in DRC, 75% in Ethiopia, 46% in Senegal, and 32% in Haiti had the capacity to provide comprehensive PAC services. Primary facilities in Bangladesh, DRC, and Nepal had critical gaps in referral, ie, effective communication with referral centres and availability of a functional vehicle for emergency transportation. In referral facilities, 74% in Bangladesh and 59% in Nepal had the provision of blood transfusion. In terms of basic PAC services in primary facilities, the capacity of Senegal (from 16% in 2015 to 38% in 2019; P = 0.001) and Haiti (from 12% in 2013 to 19% in 2018; P = 0.007) increased, but the capacity of Bangladesh decreased (from 4% in 2014 to 1% in 2017; P = 0.016) over time.</p><p><strong>Conclusions: </strong>There are substantial gaps in the capacity to provide basic and comprehensive PAC services in the selected countries. Investing in primary healthcare and improving communication and transportation should be the priority for enhancing basic PAC services, while strengthening referral hospitals to effectively handle emergencies and conduct major surgeries could significantly bolster their capacity to provide comprehensive PAC services.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"04020"},"PeriodicalIF":4.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142957290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AI-powered drug discovery for neglected diseases: accelerating public health solutions in the developing world.","authors":"M D Nahid Hassan Nishan","doi":"10.7189/jogh.15.03002","DOIUrl":"10.7189/jogh.15.03002","url":null,"abstract":"<p><p>The emergence of artificial intelligence (AI) in drug discovery represents a transformative development in addressing neglected diseases, particularly in the context of the developing world. Neglected diseases, often overlooked by traditional pharmaceutical research due to limited commercial profitability, pose significant public health challenges in low- and middle-income countries. AI-powered drug discovery offers a promising solution by accelerating the identification of potential drug candidates, optimising the drug development process, and reducing the time and cost associated with bringing new treatments to market. However, while AI shows promise, many of its applications are still in their early stages and require human validation to ensure the accuracy and reliability of predictions. Additionally, AI models are limited by the availability of high-quality data, which is often sparse in regions where neglected diseases are most prevalent. This viewpoint explores the application of AI in drug discovery for neglected diseases, examining its current impact, related ethical considerations, and the broader implications for public health in the developing world. It also highlights the challenges and opportunities presented by AI in this context, emphasising the need for ongoing research, ethical oversight, and collaboration between public health stakeholders to fully realise its potential in transforming global health outcomes.</p>","PeriodicalId":48734,"journal":{"name":"Journal of Global Health","volume":"15 ","pages":"03002"},"PeriodicalIF":4.5,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142957289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}